Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr - -


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Trial of chemotherapy utilising carboplatin, vincristine, cyclophosphamide and etoposide for the treatment of central nervous system primitive neurectodermal tumours of childhood
Back

Trial of chemotherapy utilising carboplatin, vincristine, cyclophosphamide and etoposide for the treatment of central nervous system primitive neurectodermal tumours of childhood

Not Recruiting

Open to: All Genders

Age: Child

London

Medical Conditions

Brain and nervous system cancer

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Not provided at time of registration

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 Jan 1998 28 Jan 2000

Publications

2004 Results article in https://www.ncbi.nlm.nih.gov/pubmed/15328187 patient stratification results2007 Results article in https://www.ncbi.nlm.nih.gov/pubmed/17878477 follow-up results2009 Results article in https://www.ncbi.nlm.nih.gov/pubmed/19328574 results for supratentorial primitive neuro-ectodermal tumours (SPNET) subset2004 Results article in https://www.ncbi.nlm.nih.gov/pubmed/15001263 radiotherapy duration results (added 23/01/2019)2003 Results article in https://www.ncbi.nlm.nih.gov/pubmed/12697884 results (added 23/01/2019)

Interventional

Intervention Type : Drug
Intervention Description : All patients receive surgery followed by either: 1. Schedule A: Radiotherapy alone2. Schedule B: Initial chemotherapy (carboplatin, vincristine, cyclophosphamide and etoposide) followed by radiotherapy




You can take part if:



You may not be able to take part if:


Not provided at time of registration


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • MRC Clinical Trials Unit
    London
    NW1 2DA

This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.

Dr - -



The study is sponsored by Cancer Research UK (CRUK) (UK) and funded by Cancer Research UK.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN37367725
Last updated 23 January 2019

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top